These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21453708)

  • 1. A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle.
    Wu S; Liu S; Davis CH; Stafford DW; Kulman JD; Pedersen LG
    J Theor Biol; 2011 Jun; 279(1):143-9. PubMed ID: 21453708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional insights into enzymes of the vitamin K cycle.
    Tie JK; Stafford DW
    J Thromb Haemost; 2016 Feb; 14(2):236-47. PubMed ID: 26663892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum chemical study of the mechanism of action of vitamin K carboxylase (VKC). IV. Intermediates and transition states.
    Davis CH; Ii DD; Stafford DW; Pedersen LG
    J Phys Chem A; 2007 Aug; 111(31):7257-61. PubMed ID: 17503787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantum chemical study of the mechanism of action of Vitamin K carboxylase (VKC) III. Intermediates and transition states.
    Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG
    J Mol Graph Model; 2007 Sep; 26(2):409-14. PubMed ID: 17182265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Sane DC; Hutson SM
    Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
    Wajih N; Sane DC; Hutson SM; Wallin R
    J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K-dependent carboxylation.
    Berkner KL
    Vitam Horm; 2008; 78():131-56. PubMed ID: 18374193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.
    Ingram BO; Turbyfill JL; Bledsoe PJ; Jaiswal AK; Stafford DW
    Biochem J; 2013 Nov; 456(1):47-54. PubMed ID: 24015818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K-dependent gamma-glutamylcarboxylation: an ancient posttranslational modification.
    Bandyopadhyay PK
    Vitam Horm; 2008; 78():157-84. PubMed ID: 18374194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation.
    Kaesler N; Magdeleyns E; Herfs M; Schettgen T; Brandenburg V; Fliser D; Vermeer C; Floege J; Schlieper G; Krüger T
    Kidney Int; 2014 Aug; 86(2):286-93. PubMed ID: 24429407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states.
    Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG
    J Mol Graph Model; 2007 Sep; 26(2):401-8. PubMed ID: 17182266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.
    Timson DJ
    Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum Chemical Study of the Mechanism of Action of Vitamin K Carboxylase in Solvent.
    Wu S; Liu S; Davis CH; Stafford DW; Pedersen LG
    Int J Quantum Chem; 2010 Dec; 110(15):2744-2751. PubMed ID: 21892230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X.
    Sun YM; Jin DY; Camire RM; Stafford DW
    Blood; 2005 Dec; 106(12):3811-5. PubMed ID: 16081695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
    Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and composition of the vitamin K-dependent gamma-glutamyl carboxylase-binding domain on osteocalcin.
    Houben RJ; Rijkers DT; Stanley TB; Acher F; Azerad R; Käkönen SM; Vermeer C; Soute BA
    Biochem J; 2002 May; 364(Pt 1):323-8. PubMed ID: 11988107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases.
    Shen G; Li C; Cao Q; Megta AK; Li S; Gao M; Liu H; Shen Y; Chen Y; Yu H; Li S; Li W
    FEBS J; 2022 Aug; 289(15):4564-4579. PubMed ID: 35113495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.